Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

TRANDOLAPRIL ARENA 4 mg

Angiotensin-converting enzyme inhibitor, with long-lasting action, indicated in arterial hypertension

Active Substance (INN)

Packaging

3 blisters x 10 capsules

Adverse Reaction Reporting

If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.

Adverse Reaction Form

Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.